Cempra`s bacterial skin infection drug succeeds in key study

Published 9y ago

Cempra Inc said on Friday that its oral experimental drug to treat acute bacterial skin infections met the main goal of a late-stage study, sending the company’s shares surging about 40 percent in premarket trading. More »